Changes of arterial oxygen saturation and cerebral oxygen saturation after the use of patent blue in a patient receiving breast cancer operation

Changes of arterial oxygen saturation and cerebral oxygen saturation after the use of patent blue in a patient receiving breast cancer operation - Patent blue and cerebral oxygen saturation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009416

Enrollment

100

Registered

2012-11-28

Start date

2012-11-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Sevoflurane Propofol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo breast cancer operation to which patent blue is injected.

Exclusion criteria

Exclusion criteria: Patients who have diseased in central nervous system such as cerebral infarction.

Design outcomes

Primary

Measure	Time frame
Changes in SpO2 and cerebral oxygen saturation.	—

Secondary

Measure	Time frame
Differences of changes in SpO2 and cerebral oxygen saturation between sevoflurane and propofol anesthesia.	—

Countries

Japan

Contacts

Public ContactTadahiko Ishiyama

University of Yamanashi Hospital Surgical Center

ishiyama@yamaanshi.ac.jp055-273-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026